The cholinergic neuronal phenotype in Alzheimer's disease

Metabolic Brain Disease

Volumn 15, Issue 1, 2000, Pages 45-64

  Blusztajn, Jan Krzysztof ^a   Berse, Brygida ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Apolipoprotein E; Beta amyloid; Choline acetyltransferase; Phosphatidylcholine; Vesicular acetylcholine transporter

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CHOLINE ACETYLTRANSFERASE; PHOSPHOLIPID; VERY LOW DENSITY LIPOPROTEIN; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CHOLINERGIC NERVE CELL; CYTOTOXICITY; NEUROPROTECTION; PHENOTYPE; PHOSPHOLIPID METABOLISM; PROTEIN EXPRESSION;

ACETYLCHOLINE; ALZHEIMER DISEASE; CARRIER PROTEINS; CHOLINE O-ACETYLTRANSFERASE; CHROMOSOME MAPPING; HUMANS; MEMBRANE TRANSPORT PROTEINS; NEURONS; PHENOTYPE; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0033932892     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011161718572     Document Type: Article

References (178)

1. Abe, E., Casamenti, F., Giovannelli, L., Scali, C. and Pepeu, G. (1994). Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res. 636:162-164.
2. Adler, J.E., Schleifer, L.S. and Black, I.B. (1989). Partial purification and characterization of a membrane-derived factor regulating neurotransmitter phenotypic expression. Proc.Natl.Acad.Sci.USA 86:1080-1083.
3. Alderson, R.F., Alterman, A.L., Barde, Y.-A. and Lindsay, R.M. (1990). Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 5:297-306.
4. Alfonso, A., Grundahl, K., Duerr, J.S., Han, H.-P. and Rand, J.B. (1993). The Caenorhabditis elegans unc-17 gene: A putative vesicular acetylcholine transporter. Science 261:617-619.
5. Arendt, T., Schindlet, C., Brückner, M.K., Eschrich, K., Bigl, V., Zedlick, D. and Marcova, L. (1997). Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J.Neurosci. 17:516-529.
6. Bahr, B.A., Clarkson, E.D., Rogers, G.A., Nuremberg, K. and Parsons, S.M. (1992a). A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles. Biochemistry 31:5752-5762.
7. Bahr, B.A., Noremberg, K., Rogers, G.A., Hicks, B.W. and Parsons, S.M. (1992b). Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan in synaptic vesicles. Biochemistry 31:5778-5784.
8. Bamber, B.A., Masters, B.A., Hoyle, G.W., Brinster, R.L. and Palmiter, R.D. (1994). Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice. Proc.Natl.Acad.Sci.USA 91:7839-7843.
9. Banner, L.R. and Patterson, P.H. (1994). Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc.Natl.Acad.Sci.USA 91:7109-7113.
10. Barany, M., Chang, Y.C., Arus, C., Rustan, T. and Frey, W.H. (1985). Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain. Lancet 1:517.
11. Bauerfeind, R., Galli, T., and De Camilli, P. (1996). Molecular mechanisms in synaptic vesicle recycling. J Neurocytol 25:701-15.
12. Behl, C., Davis, J.B., Klier, F.G. and Schubert, D. (1994a). Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:253-264.
13. Behl, C., Davis, J.B., Lesley, R. and Schubert, D. (1994b). Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-828.
14. Bejanin, S., Cervini, R., Mallet, J. and Berrard, S. (1994). A unique gene organization for two cholinergic markers, choline acetyltransferase and a putative vesicular transporter of acetylcholine. J.Biol.Chem. 269:21944-21947.
15. Bejanin, S., Habert, E., Berrard, S., Edwards, J.B., Loeffler, J.P. and Mallet, J. (1992). Promoter elements of the rat choline acetyltransferase gene allowing nerve growth factor inducibility in transfected primary cultured cells. J.Neurochem. 58:1580-1583.
16. Berrard, S., Varoqui, H., Cervini, R., Israël, M., Mallet, J. and Diebler, M.-F. (1995). Coregulation of two embedded gene products, choline acetyltransferase and the vesicular acetylcholine transporter. J.Neurochem. 65:939-942.
17. Berse, B. and Blusztajn, J.K. (1995). Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor a, cAMP, and leukemia inhibitory factor ciliary neurotrophic factor signaling pathways in a murine septal cell line. J. Biol. Chem. 270:22101-22104.
18. Berse, B. and Blusztajn, J.K. (1997). Modulation of cholinergic locus expression by glucocorticoids and retinoic acid is cell-type specific. FEBS Lett. 410:175-179.
19. Berse, B., López-Coviella, I. and Blusztajn, J.K. (1998). Effect of ciliary neurotrophic factor on cholinergic gene expression: modulation by nerve growth factor and glucocorticoids. J.Physiol.(Paris) 92:409-410.
20. Berse, B., López-Coviella, I. and Blusztajn, J.K. (1999). Activation of TrkA by NGF upregulates expression of the cholinergic gene locus but attenuates the response to CNTF. Biochem. J. 342:301-308.
21. Bielarczyk, H. and Szutowicz, A. (1989). Evidence for the regulatory function of synaptoplasmic acetyl-CoA in acetylcholine synthesis in nerve endings. Biochem.J. 262:377-380.
22. Bierer, L.M., Haroutunian, V., Gabriel, S., Knott, P.J., Carlin, L.S., Purohit, D.P., Perl, D.P., Schmeidler, J., Kanof, P. and Davis, K.L. (1995). Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits. J.Neurochem. 64:749-760.
23. Blennow, K., Hesse, C. and Fredman, P. (1994). Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport 5:2534-2536.
24. Blusztajn, J.K., Liscovitch, M. and Richardson, U.I. (1987). Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Proc.Natl.Acad.Sci.USA. 84:5474-5477.
25. Blusztajn, J.K., Lopez Gonzalez-Coviella, I., Logue, M., Growdon, J.H. and Wurtman, R.J. (1990). Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Brain Res. 536:240-244.
26. Blusztajn, J.K. and Wurtman, R.J. (1983). Choline and cholinergic neurons. Science 221:614-620.
27. Bowen, D.M., Smith, C.B., White, P. and Davison, A.N. (1976). Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459-496.
28. Brown, J.W., Okonmah, A.D., Soliman, K.F.A., Carballeira, A. and Fishman, L.M. (1988). Corticosteroid effects on cholinergic enzymes in ethanol-treated fetal brain cell cultures. Experientia 44:898-900.
29. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., and Black, R. A. (1998). Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273:27765-7.
30. Cervini, R., Houhou, L., Pradat, P.F., Béjanin, S., Mallet, J. and Berrard, S. (1995). Specific vesicular acetylcholine transporter promoters lie within the first intron of the rat choline acetyltransferase gene. J.Biol.Chem. 270:24654-24657.
31. Cohen, B.M., Renshaw, P.F., Stoll, A.L., Wurtman, R.J., Yurgelun-Todd, D. and Babb, S.M. (1995). Decreased brain choline uptake in older adults - An in vivo proton magnetic resonance spectroscopy study. JAMA 274:902-907.
32. Collier, B., Poon, P. and Salehmoghaddam, S. (1972). The formation of choline and of acetylcholine by brain in vitro. J.Neurochem. 19:51-60.
33. Coyle, J.T., Oster-Granite, M.L., Reeves, R.H. and Gearhart, J.D. (1988). Down syndrome, Alzheimer's disease and the trisomy 16 mouse. TINS 11:390-394.
34. Crowley, C., Spencer, S.D., Nishimura, M.C., Chen, K.S., Pitts-Meek, S., Armanini, M.P., Ling, L.H., McMahon, S.B., Shelton, D.L., Levinson, A.D. and Phillips, H.S. (1994). Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001-1011.
35. Daniels, M.P. and Hamprecht, B. (1974). The ultrastructure of neuroblastoma glioma somatic cell hybrids. Expression of neuronal characteristics stimulated by dibutyryl adenosine 3',5' cyclic monophosphate. J. Cell Biol. 63:691-699.
36. Eiden, L.E. (1998). The cholinergic gene locus. J. Neurochem. 70:2227-2240.
37. Emerich, D.F., Lindner, M.D., Winn, S.R., Chen, E.Y., Frydel, B.R. and Kordower, J.H. (1996). Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J.Neurosci. 16:5168-5181.
38. Emerich, D.F., Winn, S.R., Hantraye, P.M., Peschanski, M., Chen, E.Y., Chu, Y., McDermott, P., Baetge, E.E. and Kordower, J.H. (1997). Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386:395-399.
39. Erickson, J.D., Varoqui, H., Schäfer, M.K.H., Modi, W., Diebler, M.-F., Weihe, E., Rand, J., Eiden, L.E., Bonner, T.I. and Usdin, T.B. (1994). Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J.Biol.Chem. 269:21929-21932.
40. Fann, M.-J. and Patterson, P.H. (1994a). Depolarization differentially regulates the effects of bone morphogenetic protein (BMP)-2, BMP-6, and activin A on sympathetic neuronal phenotype. J. Neurochem. 63:2074-2079.
41. Fann, M.-J. and Patterson, P.H. (1994b). Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc.Natl.AcadSci.USA 91:43-47.
42. Fann, M. J. and Patterson, P. H. (1995). Activins as candidate cholinergic differentiation factors in vivo. Int J Dev Neurosci 13:317-330.
43. Fernandez-Chacon, R. and Sudhof, T. C. (1999). Genetics of synaptic vesicle function: toward the complete functional anatomy of an organelle. Annu Rev Physiol 61:753-76.
44. Gage, F.H., Tuszynski, M.H., Chen, K.S., Fagan, A.M. and Higgins, G.A. (1991). Nerve growth factor function in the central nervous system. Curr.Top.Microbiol.Immunol. 165:71-94.
45. Gilmor, M.L., Counts, S.E., Wiley, R.G. and Levey, A.I. (1998). Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesion. J.Neurochem. 71:2411-2420.
46. Giovannelli, L., Casamenti, F., Scali, C., Bartolini, L. and Pepeu, G. (1995). Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 66:781-792.
47. Goedert, M., Strittmatter, W.J. and Roses, A.D. (1994). Alzheimer's disease: Risky apolipoprotein in brain. Nature 372:45-46.
48. Gordon, I., Grauer, E., Genis, I., Sehayek, E. and Michaelson, D.M. (1995). Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci.Lett. 199:1-4.
49. Green, L.A. and Tischler, A.S. (1976). Establishment of noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to NGF. Proc.Natl.Acad.Sci.USA 73:2424-2428.
50. Gruninger-Leitch, F., Berndt, P., Langen, H., Nelboeck, P., and Dobeli, H. (2000). Identification of beta-secretase-like activity using a mass spectrometry-based assay system. Nat Biotechnol 18:66-70.
51. Habecker, B.A., Tresser, S.J., Rao, M.S. and Landis, S.C. (1995). Production of sweat gland cholinergic differentiation factor depends on innervation. Dev.Biol. 167:307-316.
52. Haga, T. and Noda, H. (1973). Choline uptake systems of rat brain synaptosomes. Biochim.Biophys.Acta 291:564-575.
53. Hagg, T., Quon, D., Higaki, J. and Varon, S. (1992). Ciliary neurotrophic factor prevents neuronal degeneration and promotes low affinity NGF receptor expression in the adult rat CNS. Neuron 8:145-158.
54. Hahm, S.H., Chen, L., Patel, C., Erickson, J., Bonner, T.I., Weihe, E., Schafer, M.K. and Eiden, L.E. (1997). Upstream sequencing and functional characterization of the human cholinergic gene locus. J.Mol.Neurosci. 9:223-236.
55. Hahn, M., Hahn, S.L., Stone, D.M. and Job, T.H. (1992). Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker. Proc.Natl.Acad.Sci.U.S.A. 89:4387-4391.
56. Hama, T., Miyamoto, M., Tsukui, H., Nishio, C. and Hatanaka, H. (1989). Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci.Lett. 104:340-344.
57. Handelmann, G.E., Boyles, J.K., Weisgraber, K.H., Mahley, R.W. and Pitas, R.E. (1992). Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neuntes by rabbit dorsal root ganglion neurons in vitro. J.Lipid.Res. 33:1677-1688.
58. (1.42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat. Brain Res. 698:270-274.
59. (1.42) peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res. 695:71-75.
60. Hayashi, M. and Patel, A.J. (1987). An interaction between thyroid hormone and nerve growth factor in the regulation of choline acetyltransferase in neuronal cultures, derived from the septal-diagonal band region of the embryonic rat brain. Dev.Brain Res. 36:109-120.
61. Hefti, F., David, A. and Hartikka, J. (1984). Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293:305-311.
62. Hefti, F., Hartikka, J. and Bolger, M. (1986). Effect of thyroid hormone analogs on the activity of choline acetyltransferase in cultures of dissociated septal cells. Brain Res. 375:413-416.
63. Henke, H. and Lang, W. (1983). Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer type patients. Brain Res. 267:281-291.
64. Holler, T., Berse, B., Cermak, J.M., Diebler, M.-F. and Blusztajn, J.K. (1996). Differences in the developmental expression of the vesicular acetylcholine transporter and choline acetyltransferase in the rat brain. Neurosci.Lett. 212:107-110.
65. 1.42 suppresses acetylcholine synthesis - Possible role in cholinergic dysfunction in Alzheimer's disease. J.Biol.Chem. 272:2038-2041.
66. Hussain, I., Powell, D., Hewlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., Smith, T. S., Simmons, D. L., Walsh, F. S., Dingwall, C., and Christie, G. (1999). Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14:419-27.
67. Ishii, K., Oda, Y., Ichikawa, T. and Deguchi, T. (1990). Complementary DNAs for choline acetyltransferase from spinal cords of rat and mouse: Nucleotide sequences, expression in mammalian cells, and in situ hybridization. Mol.Brain Res. 7:151-159.
68. Junard, E.O., Montera, C.N. and Hefti, F. (1990). Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway. Exp.Neurol. 110:25-38.
69. Kamegai, M., Konishi, Y. and Tabira, T. (1990a). Trophic effect of granulocyte-macrophage colony-stimulating factor on central cholinergic neurons in vitro. Brain Res. 532:323-325.
70. Kamegai, M., Niijima, K., Kunishita, T., Nishizawa, M., Ogawa, M., Araki, M., Ueki, A., Konishi, Y. and Tabira, T. (1990b). Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo. Neuron 4:429-436.
71. Kar, S., Issa, A.M., Seto, D., Auld, D.S., Collier, B. and Quirion, R. (1998). Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocarapal slices. J. Neurochem. 70:2179-2187.
72. Kar, S., Seto, D., Gaudreau, P. and Quirion, R. (1996). β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from hippocampal slices. J.Neurosci. 16:1034-1040.
73. 3H]Vesamicol binding in human brain cholinergic deficiency disorders. Neurosci.Lett. 117:347-352.
74. Klunk, W.E., Panchalingam, K., McClure, R.J. and Pettegrew, J.W. (1992). Brain metabolic alterations associated with clinical onset and course of Alzheimer's disease. Ann.Neurol. 32:268.
75. Koh, J., Yang, L.L. and Cotman, C.W. (1990). β -Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:315-320.
76. Koliatsos, V.E., Clatterbuck, R.E., Gouras, G.K. and Price, D.L. (1991a). Biologic effects of nerve growth factor on lesioned basal forebrain neurons. Ann.NY Acad.Sci. 640:102-109.
77. Koliatsos, V.E., Clatterbuck, R.E., Nauta, H.J.W., Knüsel, B., Burton, L.E., Hefti, F.F., Mobley, W.C. and Price, D.L. (1991b). Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann.Neurol. 30:831-840.
78. Koliatsos, V.E., Clatterbuck, R.E., Winslow, J.W., Cayouette, M.H. and Price, D.L. (1993). Brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 10:359-367.
79. Koliatsos, V.E., Nauta, H.J.W., Clatterbuck, R.E., Holtzman, D.M., Mobley, W.C. and Price, D.L. (1990). Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J.Neurosci. 10:3801-3813.
80. Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K. and Yankner, B.A. (1991). An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc.Natl.Acad.Sci.USA 88:7247-7251.
81. Kushima, Y. and Hatanaka, H. (1992). Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci.Lett. 143:110-114.
82. LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S. and Frail, D.E. (1994). Isoform-specific binding of apolipoprotein E to β-amyloid. J.Biol.Chem. 269:23403-23406.
83. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz, F. (1999). Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 96:3922-7.
84. Lee, H.-C., Fellenz-Maloney, M.-P., Liscovitch, M. and Blusztajn, J.K. (1993). Phospholipase D-catalyzed hydrolysis of phosphatidylcholine provides the choline precursor for acetylcholine synthesis in a human neuronal cell line. Proc.Natl.Acad.Sci.USA 90:10086-10090.
85. 14C]pyruvate in rat striatal slices. J.Neurochem. 20:1083-1097.
86. Lemere, C.A., Blusztajn, J.K., Yamaguchi, H., Wisniewski, T., Saido, T.C. and Selkoe, D.J. (1996). Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol.Disease 3:16-32.
87. Li, Y., Holtzman, D.M., Kromer, L.F., Kaplan, D.R., Chua-Couzens, J., Clary, D.O., Knüsel, B. and Mobley, W.C. (1995). Regulation of TrkA and ChAT expression in developing rat basal forebrain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J.Neurosci. 15:2888-2905.
88. Li, Y.-P., Baskin, F., Davis, R. and Hersh, L.B. (1993). Cholinergic neuron-specific expression of the human choline acetyltransferase gene is controlled by silencer elements. J.Neurochem. 61:748-751.
89. Lönnerberg, P., Lendahl, U., Funakoshi, H., Arhlund-Richter, L., Persson, H. and Ibáñez, C.F. (1995). Regulatory region in choline acetyltransferase gene directs developmental and tissue-specific expression in transgenic mice. Proc.Natl.Acad.Sci.USA 92:4046-4050.
90. Lönnerberg, P., Schoenherr, C.J., Anderson, D.J. and Ibáñez, C.F. (1996). Cell type-specific regulation of choline acetyltransferase gene expression. Role of the neuron-restrictive silencer element and cholinergic-specific enhancer sequences. J.Biol.Chem. 271:33358-33365.
91. Maden, M. and Holder, N. (1991). The involvement of retinoic acid in the development of the vertebrate central nervous system. Development 2:87-94.
92. Mahley, R.W. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
93. Marchbanks, R.M. and Wonnacott, S. (1979). Relationship of choline uptake to acetylcholine synthesis and release. Prog.Brain Res. 49:77-88.
94. McGeer, P.L., McGeer, E.G., Suzuki, J., Dolman, C.E. and Nagai, T. (1984). Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 34:741-745.
95. McManaman, J.L., Crawford, F.G., Stewart, S.S. and Appel, S.H. (1988). Purification of a skeletal muscle polypeptide which stimulates choline acetyltransferase activity in cultured spinal cord neurons. J.Biol.Chem. 263:5890-5897.
96. 31P NMR spectroscopy. Phospholipids in the nervous system: Biochemical and molecular pathology. (Bazan, N.G., Horrocks, L.A., and Toffano, G., eds) pp. 243-250, Liviana Press, Padua
97. Milner, T.A. (1991). Cholinergic neurons in the rat septal complex: Ultrastructural characterization and synaptic relations with catecholaminergic terminals. J.Comp.Neurol. 314:37-54.
98. Misawa, H., Ishii, K. and Deguchi, T. (1992). Gene expression of mouse choline acetyltransferase. Alternative splicing and identification of a highly active promoter region. J.Biol.Chem. 267:20392-20399.
99. Misawa, H., Takahashi, R. and Deguchi, T. (1993). Transcriptional regulation of choline acetyltransferase gene by cyclic AMP. J.Neurochem. 60:1383-1387.
100. Misawa, H., Takahashi, R. and Deguchi, T. (1995). Coordinate expression of vesicular acetylcholine transporter and choline acetyltransferase in sympathetic superior cervical neurones. Neuroreport 6:965-968.
101. Montero, C.N. and Hefti, F. (1988). Rescue of lesioned septal cholinergic neurons by nerve growth factor: Specificity and requirement for chronic treatment. J.Neurosci. 8:2986-2999.
102. Naciff, J. M., Behbehani, M. M., Misawa, H., and Dedman, J. R. (1999). Identification and transgenic analysis of a murine promoter that targets cholinergic neuron expression. J Neurochem 72:17-28.
103. Naciff, J.M., Misawa, H. and Dedman, J.R. (1997). Molecular characterization of the mouse vesicular acetylcholine transporter gene. Neuroreport 8:3467-3473.
104. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. and Pitas, R.E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.
105. Nathan, B.P., Chang, K.C., Bellosta, S., Brisch, E., Ge, N.F., Mahley, R.W. and Pitas, R.E. (1995). The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J.Biol.Chem. 270:19791-19799.
106. Naumann, T., Kermer, P. and Frotscher, M. (1994). Fine structure of rat septohippocampal neurons. III. Recovery of choline acetyltransferase immunoreactivity after fimbria-fornix transection. J.Comp.Neurol. 350:161-170.
107. Nitsch, R.M., Blusztajn, J.K., Pittas, A.G., Slack, B.E., Growdon, J.H. and Wurtman, R.J. (1992). Evidence for a membrane defect in Alzheimer disease brain. Proc.Natl.Acad.Sci.USA 89:1671-1675.
108. Parducz, A., Joo, F. and Toldi, J. (1986). Formation of synaptic vesicles in the superior cervical ganglion of the cat: Choline dependency. Exp.Brain Res. 63:221-224.
109. Parducz, A., Kiss, Z. and Joo, F. (1976). Changes of the phosphatidylcholine content and the number of synaptic vesicles in relation to neurohumoral transmission in sympathetic ganglia. Experientia 32:1520-1521.
110. Parsons, S.M., Bahr, B.A., Gracz, L.M., Kaufman, R., Kornreich, W.D., Nilsson, L. and Rogers, G.A. (1987). Acetylcholine transport: fundamental properties and effects of pharmacologic agents. Ann.NY.Acad.Sci. 493:220-233.
111. Patel, A.J., Hayashi, M. and Hunt, A. (1988). Role of thyroid hormone and nerve growth factor in the development of choline acetyltransferase and other cell-specific marker enzymes in the basal forebrain of the rat. J.Neurochem. 50:803-811.
112. Patterson, P.H. and Chun, L.L.Y. (1977). The induction of acetylcholine synthesis in primary cultures of dissociated rat sympathetic neurons. Dev.Biol. 56:263-280.
113. Pearson, R.C.A., Sofroniew, M.V., Cuello, A.C., Powell, T.P.S., Eckenstein, F., Esiri, M.M. and Wilcock, G.K. (1983). Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of Alzheimer type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res. 289:375-379.
114. Pedersen, W.A., Berse, B., Schüler, U., Wainer, B.H. and Blusztajn, J.K. (1995). All-trans- and 9-cis-retinoic acid enhance the cholinergic properties of a murine septal cell line: Evidence that the effects are mediated by activation of retinoic acid receptor alpha. J.Neurochem. 65:50-58.
115. Pedersen, W.A. and Blusztajn, J.K. (1997). Characterization of the acetylcholine-reducing effect of the amyloid-β peptide in mouse SN56 cells. Neurosci.Lett. 239:77-80.
116. Pedersen, W.A., Guo, Q., Hartman, B.K., and Mattson, M.P. (1997). Nerve growth factor-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1. J. Biol. Chem., 272:22397-22400.
117. Pedersen, W.A., Kloczewiak, M.A. and Blusztajn, J.K. (1996). Amyloid β-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc.Natl.Acad.Sci.USA 93:8068-8071.
118. Perry, E.K., Tomlinson, B.E., Blessed, G., Bergman, K., Gibson, P.H. and Perry, R.H. (1978). Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br.Med.J. 2:1457-1459.
119. Perry, R.H., Candy, J.M., Perry, E.K., Irving, D., Blessed, G., Fairburn, F. and Tomlinson, B.E. (1982). Extensive loss of choline acetyltransferase activity is not related to neuronal loss in nucleus of Meynert in Alzheimer's disease. Neurosci.Lett. 33:311-315.
120. 31P NMR changes in Alzheimer's and Huntington's disease brain. Neurology 34(suppl 1):281.
121. Pike, C.J., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W. (1991). In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314.
122. Pirttila, T., Mehta, P.D., Soininen, H., Kim, K.S., Heinonen, O., Paljarvi, L., Kosunen, O., Riekkinen, P. and Wisniewski, H.M. (1996). Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain. Arch.Neurol. 53:189-193.
123. Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:525-530.
124. Poirier, J., Delisle, M.C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., Gilfix, B.M. and Gauthier, S. (1995). Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc.Natl.Acad.Sci.USA 92:12260-12264.
125. Poirier, J., Hess, M., May, P.C. and Finch, CE. (1991). Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res.Mol.Brain Res. 11:97-106.
126. Prasad, K.N. and Kumar, S. (1974). Cyclic AMP and the differentiation of neuroblastoma cells in culture. Control of Proliferation in Animal Cells. (Clarkson, B. and Baserga, R., eds) pp. 581-594, Cold Spring Harbor Laboratory,
127. Quastel, J.H., Tennenbaum, M. and Wheatley, A.H.M. (1936). Choline ester formation in, and cholinesterase of, tissues in vitro. Biochem.J. 30:1668-1681.
128. Rao, M.S. and Landis, S.C. (1990). Characterization of a target-derived neuronal cholinergic differentiation factor. Neuron 5:899-910.
129. Rao, M.S., Patterson, P.H. and Landis, S.C. (1992). Multiple cholinergic differentiation factors are present in footpad extracts: Comparison with known cholinergic factors. Development 116:731-744.
130. Rao, M.S., Sun, Y., Escary, J.L., Perreau, J., Tresser, S., Patterson, P.H., Zigmond, R.E., Brulet, P. and Landis, S.C. (1993). Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11:1175-1185.
131. Roghani, A., Feldman, J., Kohan, S.A., Shirzadi, A., Gundersen, C.B., Brecha, N. and Edwards, R.H. (1994). Molecular cloning of a putative vesicular transporter for acetylcholine. Proc.Natl.Acad.Sci.USA 91:10620-10624.
132. Roheim, P.S., Carey, M., Forte, T. and Vega, G.L. (1979). Apolipoproteins in human cerebrospinal fluid. Proc.Natl.Acad.Sci.U.S.A. 76:4646-4649.
133. 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience 35:327-333.
134. Saadat, S., Sendtner, M. and Rohrer, H. (1989). Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture. J. Cell Biol 108:1807-1816.
135. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D. and Roses, A.D. (1993), Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc.Natl.Acad.Sci.USA 90 :9649-9653.
136. Schotzinger, R., Yin, X. and Landis, S. (1994). Target determination of neurotransmitter phenotype in sympathetic neurons. J.Neurobiol. 25:620-639.
137. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y. and Kimura, H. (1995). Amyloid peptides are toxic via a common oxidative mechanism. Proc.Natl.Acad.Sci.USA 92:1989-1993.
138. Selkoe, D.J. (1994). Normal and abnormal biology of the β-amyloid precursor protein. Annu.Rev.Neurosci. 17:489-517.
139. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S. M., Wang, S., Walker, D., John, V. and others (1999). Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402:537-40.
140. Slotkin, T.A., Nemeroff, C.B., Bissette, G. and Seidler, F.J. (1994). Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J.Clin.Invest. 94:696-702.
141. Sofroniew, M.V., Cooper, J.D., Svendsen, C.N., Crossman, P., Ip, N.Y., Lindsay, R.M., Zafra, F. and Lindholm, D. (1993). Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3. J.Neurosci. 13:5263-5276.
142. Sofroniew, M.V., Galletly, N.P., Isacson, O. and Svendsen, C.N. (1990). Survival of adult basal forebrain cholinergic neurons after loss of target neurons. Science 247:338-342.
143. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.-M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D. (1994). Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc.Natl.Acad.Sci.USA 91:11183-11186.
144. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. (1993a). Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc.Natl.Acad.Sci.USA 90:1977-1981.
145. Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.-M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D. (1993b). Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Aizheimer disease. Proc.Natl.Acad.Sci.USA 90:8098-8102.
146. Südhof, T.C. (1995). The synaptic vesicle cycle: A cascade of protein-protein interactions. Nature 375:645-653.
147. Suszkiw, J.B. and Pilar, G. (1976). Selective localization of a high affinity choline uptake system and its role in ACh formation in cholinergic nerve terminals. J.Neurochem. 26 :1133-1138.
148. Svendsen, C.N., Cooper, J.D. and Sofroniew, M.V. (1991). Trophic factor effects on septal cholinergic neurons. Ann.NY Acad.Sci. 640:91-94.
149. Szutowicz, A., Bielarczyk, H. and Lysiak, W. (1981). The role of citrate derived from glucose in the acetylcholine synthesis in rat brain synaptosomes, Int.J.Biochem. 13:887-892.
150. Szutowicz, A, Jankowska, A., Blusztajn, J. K., and Tomaszewicz, M. (1999). Acetylcholine and acetyl-CoA metabolism in differentiating SN56 septal cell line. J Neurosci Res 57:131-6.
151. Szutowicz, A., Morrison, M.R. and Srere, P.A. (1983). The enzymes of acetyl-CoA metabolism in differentiating cholinergic (S-20) and noncholinergic (NIE-115) neuroblastoma cells. J.Neurochem. 40:1664-1670.
152. Szutowicz, A., Srere, P.A., Allen, C.N. and Crawford, I.L. (1982a). Effects of septal lesions on enzymes of acetyl-CoA metabolism in the cholinergic system of the rat hippocampus. J.Neurochem. 39:458-463.
153. Szutowicz, A., Stepien, M., Bielarczyk, H., Kabata, J. and Lysiak, W. (1982b). ATP citrate lyase in cholinergic nerve endings. Neurochem.Res. 7:799-810.
154. Takei, N., Kuramoto, H., Endo, Y. and Hatanaka, H. (1997). NGF and BDNF increase the immunoreactivity of vesicular acetylcholine transporter in cultured neurons from the embryonic rat septum. Neurosci.Lett. 226:207-209.
155. Tian, X.T., Sun, X.Y. and Suszkiw, J.B. (1996). Developmental age-dependent upregulation of choline acetyltransferase and vesicular acetylcholine transporter mRNA expression in neonatal rat septum by nerve growth factor. Neurosci. Lett. 209:134-136.
156. Toran-Allerand, C.D., Miranda, R.C., Bentham, W.D.L., Sohrabji, F., Brown, T.J., Hochberg, R.B. and MacLusky, N.J. (1992). Estrogen receptors
157. Tucek, S. (1990). The synthesis of acetylcholine: twenty years of progress. Prog.Brain Res. 84:467-477.
158. Tuszynski, M.H., Buzsaki, G. and Gage, F.H. (1990). Nerve growth factor infusions combined with fetal hippocampal grafts enhance reconstruction of the lesioned septohippocampal projection. Neuroscience 36:33-44.
159. Tuszynski, M.H., Sang U, H., Yoshida, K. and Gage, F.H. (1991). Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann.Neurol. 30:625-636.
160. Tuszynski, M.H., U, H.S., Amaral, D.G. and Gage, F.H. (1990). Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J.Neurosci. 10:3604-3614.
161. Ulus, I.H., Wurtman, R.J., Mauron, C. and Blusztajn, J.K. (1989). Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res. 484:217-227.
162. Usdin, T.B., Eiden, L.E., Bonner, T.I. and Erickson, J.D. (1995). Molecular biology of the vesicular ACh transporter. TINS 18:218-224.
163. Vaca, K., Stewart, S.S. and Appel, S.H. (1989). Identification of basic fibroblast growth factor as a cholinergic growth factor from human muscle. J.Neurosci.Res. 23:55-63.
164. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999). Beta-secretase cleavage of Aizheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-41.
165. Vizi, E.S., Kobayashi, O., Torocsik, A., Kinjo, M., Nagashima, H., Manabe, N., Goldiner, P.L., Potter, P.E. and Foldes, F.F. (1989). Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release. Neuroscience 31:259-267.
166. Vogels, O.J.M., Broere, C.A.J., Ter Laak, H.J., Ten Domkelaar, H.J., Nieuwenhuys, R. and Schulte, B.P.M (1990). Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol.Aging 11:3-13.
167. Weisgraber, K.H. and Mahley, R.W. (1996). Human apolipoprotein E: the Alzheimer's disease connection FASEB J. 10:1485-1494.
168. Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T. and DeLong, M.R. (1982). Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239.
169. Whitson, J.S., Glabe, C.G., Shintani, E., Abcar, A. and Cotman, C.W. (1990). β-Amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci.Lett. 110:319-324.
170. Whitson, J.S., Selkoe, D.J. and Cotman, C.W. (1989). Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243:1488-1490.
171. Wolfe, M. S., De Los Angeles, J., Miller, D. D., Xia, W., and Selkoe, D. J. (1999). Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. Biochemistry 38:11223-30.
172. Wu, D. and Hersh, L.B. (1994). Choline acetyltransferase: Celebrating its fiftieth year. J.Neurochem. 62:1653-1663.
173. Yamamori, T., Fukada, K., Aebersold, R., Korsching, S., Fann, M.-J. and Patterson, P.H. (1989). The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246:1412-1416.
174. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashier, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., Carter, D. B., Tomasselli, A. G., Parodi, L. A., Heinrikson, R. L., and Gurney, M. E. (1999). Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402:533-7.
175. Yankner, B.A., Caceres, A. and Duffy, L.K. (1990a). Nerve growth factor potentiates the neurotoxicity of β amyloid. Proc.Natl.Acad.Sci.USA 87:9020-9023.
176. Yankner, B.A., Dawes, L.R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M.L. and Neve, R.L. (1989). Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420.
177. Yankner, B.A., Duffy, L.K. and Kirschner, D.A. (1990b). Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250:279-282.
178. Yates, C.M., Simpson, J., Gordon, A., Maloney, A.F., Allison, Y., Ritchie, I.M. and Urquhart, A. (1983). Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. Brain Res. 280:119.